Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Neuroendocrine tumour (NET), Non melanoma skin cancer, Skin cancer
Closed
Phase 2
This trial is looking at a drug called pazopanib for merkel cell skin cancer that has spread.
The trial is supported by Cancer Research UK.
Recruitment start: 1 December 2012
Recruitment end: 9 February 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Paul Nathan
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
GlaxoSmithKline (GSK)
NIHR Clinical Research Network: Cancer
University of Birmingham
This is Cancer Research UK trial number CRUK/11/015.
Last reviewed: 02 Oct 2023
CRUK internal database number: 7402
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
